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Both Decreased and Increased Heart Rate Variability on the Standard
10-Second Electrocardiogram Predict Cardiac Mortality In the Elderly
The Rotterdam Study
Martne C. de Bruyne,1"3 Jan A. Kors,2 Arno W. Hoes,u Peter Klootwijk,4 Jacqueline M. Dekker,6
Albert Hofman,1 Jan H. van Bemmel,2 and Diederick E. Grobbeeu
Decreased heart rate variability has been associated with an adverse prognosis in patients after myocardial
infarction. Studies carried out in the population at large show contradictory results. The authors examined the
association between heart rate variability on a standard 10-second electrocardiogram and cardiac and all-cause
mortality in the Rotterdam Study, a population-based cohort study of men and women aged £55 years, using
data collected between 1990 and 1996 (mean follow-up = 4 years). Heart rate variability, taken as the standard
deviation of normal R-R intervals (SDNN), was computed by means of the Modular ECG Analysis System. After
exclusion of subjects with arrhythmia and those with fewer than six normal R-R intervals, the study population
consisted of 2,088 men and 3,184 women. Cox's proportional hazards model was used to examine the age- and
sex-adjusted risk for cardiac, noncardiac, and total mortality in relation to quartiles of SDNN, using the third
quartile of SDNN as the reference category. Subjects in the lowest quartile of SDNN relative to those in the third
quartile had an 80 percent age- and sex-adjusted increased risk for cardiac mortality (hazard ratio = 1.8; 95%
confidence interval: 1.0, 3.2). Interestingly, for subjects in the highest quartile of SDNN, an even more
pronounced risk for cardiac mortality was present (hazard ratio = 2.3; 95% confidence interval: 1.3, 4.0).
Additional adjustment for possible confounders did not materially change the risk estimates. The authors
conclude that heart rate variability measured on the standard 10-second electrocardiogram can be used to
identify older men and women with an increased risk for cardiac mortality. In the elderly, increased heart rate
variability is an even stronger indicator of cardiac mortality than decreased heart rate variability. Further studies
are needed to confirm these findings and to elucidate their physiologic meaning. Am J Epidemiol 1999;150:
1282-8.
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Heart rate variability (HRV) has been put forward as
a promising marker of autonomic activity (1). HRV is
influenced by various physiologic and pathologic con-
ditions, such as aging (2, 3), respiration (4), diabetic
neuropathy (5), congestive heart failure (6), and coro-
nary heart disease (7-9). In the last two decades, ample
evidence has emerged that reduced HRV has adverse
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prognostic implications in patients after myocardial
infarction (10-15).
Several studies reported an association between
decreased HRV and all-cause and cardiac mortality in
middle-aged and elderly subjects (16-20). However,
no association of reduced HRV with cardiac and all-
cause mortality was found in elderly men and women
in the Bronx Aging Study (21). Surprisingly, in the lat-
ter study, an association of increased HRV with cardiac
events was present in women. A similar association
was reported for elderly men in the Zutphen Study
(17).
The task force on HRV recommends that, in order to
standardize clinical studies, only two types of HRV
measurements should be used (1): 1) short term mea-
surements on 5-minute electrocardiograms made
under physiologically stable conditions, processed by
frequency-domain methods, and 2) 24-hour recordings
processed by time-domain methods. However, two
prior population-based studies restricted to men
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reported an association between decreased HRV, mea-
sured in 10-beat electrocardiograms (18) and 20-second
electrocardiograms (17), and total and cardiac mortal-
ity. Provided that the predictive value is established, the
standard 12-lead electrocardiogram would offer a use-
ful tool for risk stratification in large populations, as it
is much easier and less costly to obtain than the stan-
dardized 5-minute electrocardiogram or the 24-hour
Holter electrocardiogram.
In the present study, we examined the association
between decreased and increased HRV on the standard
10-second electrocardiogram and cardiac and all-cause
mortality in the Rotterdam Study, a population-based
cohort study of men and women aged >55 years.
MATERIALS AND METHODS
Study population and baseline data collection
This study was part of the Rotterdam Study, a
population-based cohort study aimed at assessing the
occurrence of and risk factors for chronic diseases in the
elderly. The objectives and methods of the Rotterdam
Study are described in detail elsewhere (22). Briefly, all
men and women aged >55 years living in the Rotterdam
district of Ommoord were invited to participate
(response rate = 78 percent). Baseline data on 7,129
participants, collected from 1990 to 1993, included an
electrocardiogram and information on history of cardio-
vascular disease, cardiovascular disease risk factors,
and use of coffee, alcohol, and medications.
Digitally stored electrocardiographic data were
available for 6,160 (86 percent) participants. Electro-
cardiographic data were missing for 14 percent of the
participants, mainly because of temporary technical
problems with the electrocardiographic recorder.
Blood pressure was calculated as the average of two
consecutive measurements taken with a random-zero
mercury manometer. Body mass index was calculated
as weight (kg)/height (m)2. Hypertension was defined
as a systolic blood pressure greater than 160 mmHg or
a diastolic blood pressure greater than 95 mmHg or use
of antihypertensive medication. Diabetes mellitus was
defined as a nonfasting blood glucose level greater
than 11.1 mmol/liter or use of antidiabetic medication.
History of myocardial infarction was defined as self-
reported myocardial infarction with hospital admis-
sion, or a myocardial infarction indicated on the elec-
trocardiogram. The presence of angina pectoris was
established through the Rose questionnaire (23).
Subjects with arrhythmia (n = 232 (162 with atrial
fibrillation, 14 with atrial flutter, 23 with atrial rhythm,
32 with ideoventricular rhythm, and one with
supraventricular tachycardia)) and subjects for whom
less than six R-R intervals on the electrocardiogram
could be analyzed for HRV measurements (n = 251)
were excluded. In addition, 345 subjects without
follow-up data (mainly because they had moved to
unknown locations) and 60 subjects with electrocar-
diograms of poor technical quality in which cardiac
rhythm could not be analyzed were excluded. The final
study population consisted of 2,088 men and 3,184
women.
Follow-up procedures
The follow-up period, starting at the baseline exami-
nation and lasting until April 1996 for the present
analysis, was 3-6 (mean = 4) years. Information on the
vital status of participants was obtained at regular inter-
vals from the municipal authorities in Rotterdam.
Information on fatal and nonfatal endpoints was
obtained from the general practitioners working in the
study district of Ommoord. These general practitioners,
covering about 85 percent of the cohort, all have their
practice computerized, and they report possible fatal
and nonfatal events among participants to the
Rotterdam Study data center in computer files on a reg-
ular basis. All possible events reported by the general
practitioners are verified by research physicians from
the Rotterdam Study, through review of patient records
of the participating general practitioners and of medical
specialists. In April 1996, the medical records of those
participants with general practitioners from outside the
Ommoord area (-15 percent of the cohort) were
checked by research physicians, and additional infor-
mation for coding was collected on all possible events.
For deceased participants, information on the cause
and circumstances of death was obtained shortly after
the death was reported by the general practitioner or
municipal authorities. The information was obtained
from the general practitioner by questionnaire and by
scrutinizing hospital discharge records in cases of hos-
pital admittance or referral.
Complete follow-up information was available for
94 percent of the Rotterdam Study population.
Differences in baseline characteristics between partic-
ipants with and without follow-up data were examined
using one-way analysis of covariance, adjusting for
age and sex when appropriate. Persons without follow-
up data were, on average, older (73.9 years vs. 70.4
years) and had lower prevalences of hypertension (25
percent vs. 30 percent) and diabetes mellitus (10 per-
cent vs. 14 percent). No other differences in baseline
characteristics were found.
Classification of fatal and nonfatal events was based
on the International Classification of Diseases, Tenth
Revision (ICD-10) (24). We defined cardiac mortality as
death from myocardial infarction (ICD-10 codes
121-124), chronic ischemic heart disease (ICD-10 code
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125), pulmonary embolism or other pulmonary heart
disease (ICD-10 codes 126-128), cardiomyopathy
(ICD-10 codes 142-143), cardiac arrest (ICD-10 code
146), arrhythmia (ICD-10 codes 147-149), heart failure
(ICD-10 code 150), or sudden cardiac death. Sudden
cardiac death was defined as death occurring within 1
hour after onset of symptoms or unwitnessed death in
which a cardiac cause could not be excluded (25, 26).
All events were classified independently by two
research physicians. If there was disagreement, a con-
sensus was reached in a separate session. Finally, all
events were verified by a medical expert in the field of
cardiovascular disease. In cases of discrepancies, the
judgment of this expert was considered definite.
Electrocardiogram Interpretation and
measurements
A 12-lead resting electrocardiogram was recorded
using an ACTA cardiograph (Esaote Biomedica,
Florence, Italy) with a sampling frequency of 500 Hz,
and results were stored digitally. All electrocardio-
grams were processed by the Modular ECG Analysis
System to obtain electrocardiographic measurements
and diagnostic interpretations. The Modular ECG
Analysis System has been evaluated extensively
(27-30).
Only R-R intervals between two adjacent normal
dominant beats were used to compute mean heart rate
and HRV, taken as the standard deviation of normal
R-R intervals (SDNN). Both premature ventricular and
supraventricular complexes were considered abnor-
mal. The overall Q-T interval was determined on a rep-
resentative beat for all 12 leads together. To adjust the
Q-T interval for heart rate, we calculated Q-Tc accord-
ing to Bazett's formula (31). Left ventricular hypertro-
phy was determined using voltage as well as repolar-
ization criteria. Negative T waves were defined as
negative T-wave deflections of at least 1.0 mm in any
of the following leads: I-DI, aVR, aVF, and V2-V6.
Data analysis
SDNN was categorized into quartiles, with 25th,
50th, and 75th percentile values of 9.6, 15.2, and 25.9
ms, respectively.
To evaluate the association between HRV and poten-
tially confounding factors and other electrocardio-
graphic factors, we examined differences in the distri-
bution of selected baseline characteristics between
subjects in quartiles of SDNN by one-way analysis of
covariance, adjusting for age and sex when appropri-
ate. Because a U-shaped relation was apparent
between several determinants and SDNN in which the
lowest risk was present in the third quartile, we per-
formed separate analyses for decreased HRV (analyz-
ing the lowest three quartiles) and increased HRV
(analyzing the highest two quartiles). All determinants
that showed a statistically significant (p < 0.05) asso-
ciation with SDNN in one of these analyses was con-
sidered a possible confounder.
Cox's proportional hazards model was used to
examine the risk for cardiac, noncardiac, and total
mortality in relation to quartiles of SDNN, adjusted for
two sets of confounders: 1) age and sex and 2) all pos-
sible confounders resulting from the analysis of
covariance. The third quartile of SDNN was taken as
the reference category. To minimize the effect of miss-
ing data in the multivariate analysis, we replaced miss-
ing values for categorical variables with dummy vari-
ables (32). Missing values for continuous variables
were replaced by the variable's average value and a
dummy variable to indicate whether an imputed value
was added to the model.
Subgroup analyses were performed to examine
whether age (ST75 years vs. >75 years), sex, history of
myocardial infarction, and presence of ectopic beats
influenced the association between SDNN and cardiac
mortality.
RESULTS
Baseline characteristics of participants are presented
by quartile of SDNN in table 1. In the analysis of deter-
minants of decreased HRV, statistically significant dif-
ferences existed between the three groups with regard to
age, sex, body mass index, and diabetes mellitus. The
electrocardiographic characteristics associated with
decreased SDNN were mean R-R interval and overall
Q-Tc interval. Increased HRV, comparing the highest
two quartiles, was associated with age, sex, mean R-R
interval, the presence of negative T waves, and prema-
ture ventricular and supraventricular complexes.
During follow-up, 222 (10.6 percent) men and 238
(7.5 percent) women died; 69 (3.3 percent) men and 63
(2.0 percent) women died from a cardiac cause. Subjects
in the lowest quartile of SDNN relative to those in the
third quartile had an 80 percent age- and sex-adjusted
increased risk for cardiac mortality (hazard ratio =1.8;
95 percent confidence interval: 1.0, 3.2) (table 2). The
corresponding hazard ratios for noncardiac mortality
and all-cause mortality were 1.3 (95 percent confidence
interval: 0.9, 1.8) and 1.4 (95 percent confidence inter-
val: 1.0, 1.8), respectively. Interestingly, for subjects in
the highest quartile of SDNN compared with those in
the third quartile, we found an even more pronounced
risk for cardiac mortality (hazard ratio = 2.3; 95 percent
confidence interval: 1.3,4.0).
The risks for cardiac and noncardiac mortality asso-
ciated with both decreased and increased SDNN were
Am J Epidemiol Vol. 150, No. 12, 1999
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TABLE 1. Baseline characteristics of participants, by quartlle of SONNf: The Rotterdam Study,
1990-1993*
Characteristic
Mean age (years)
Sex (% women)
Mean systolic Wood pressure (mmHg)
Mean diastolic blood pressure (mmHg)
Mean body mass indexH
Mean serum cholesterol level (mmol/liter)
Cigarette smoking (%)
Mean coffee intake (mg/day)
Mean alcohol intake (mg/day)
Hypertension (%)
Diabetes mellitus (%)
Angina pectoris (%)
Myocardial infarction (%)
Use of cardiovascular medication (%)
Negative T waves (%)
Left ventricular hypertrophy on electro-
cardiogram (%)
Mean R-R interval (ms)
Overall Q-Tc interval (ms)
Presence of premature ventricular
complex (%)
Presence of premature supraventricular
complex (%)
All subjects
(n = 5,272)
68.7 (8.8)§
60.4
139.4(22.3)
73.6 (11.5)
26.4 (3.7)
6.6(1.2)
21.4
482 (238)
10.3(15.3)
29.3
12.3
6.7
12.1
33.9
6.8
4.4
867(140)
430.9 (26.2)
2.8
2.7
1
(<9.6)
7 0 . 6 "
59.9*
140.7
74.2
26.7*
6.7
21.4
483
10.7
31.5
14.8*
6.9
13.3
34.6
7 . 5 "
4.0
801 • •
4 3 8 "
2.9
0.6
Quartile of SDNN
2
(9.6-<15.2)
69.1
64.4
139.7
73.7
26.4
6.6
20.8
481
9.9
30.1
12.0
7.0
11.4
34.2
8.4
4.9
858
432
2.2
0.2
3
(15.2-<25.9)
67.4
62.1
139.5
73.5
26.3
6.6
20.7
474
10.0
29.4
11.3
7.0
11.3
34.5
5.2
4.3
898
428
2.6
0.2
4
(£25.9)
68.0*
54.9**
137.2
73.0
26.1
6.7
22.7
490
10.9
26.0
10.9
5.7
12.0
32.2
7 . 4 "
4.3
911*
426
3.9*
10.3*
•p<0.05; **p<0.01.
t SDNN, standard deviation of normal R-R intervals (in ms).
$ p values are for equality of quartile-speclfic values in quartiles of SDNN, adjusted for age and sex.
§ Numbers in parentheses, standard deviation.
H Weight (kg)/height (m)2.
more pronounced in women than in men. The risks for
cardiac mortality associated with increased HRV were
more pronounced in subjects with a history of myocar-
dial infarction and in subjects aged <75 years (table 2).
Because premature ventricular or supraventricular
complexes occurred more frequently in persons with
increased SDNN, we performed a separate analysis
excluding subjects with premature complexes on their
electrocardiogram. However, this did not change the
results (data not shown).
We carried out analyses with additional adjustment
for body mass index, diastolic blood pressure, diabetes
mellitus, overall Q-Tc interval, mean R-R interval, and
the presence of negative T waves (table 3). The hazard
ratios did not change substantially for any endpoints.
DISCUSSION
This study showed that both decreased HRV and
increased HRV, as measured by the standard 10-second
electrocardiogram, are associated with cardiac mortal-
ity in the elderly. These risks were more pronounced in
elderly people aged <T75 years, in women, and in sub-
jects with a history of myocardial infarction. In addi-
tion, the results indicate that both decreased HRV and
increased HRV are associated with death from noncar-
diac causes in women.
Sex differences in the mortality risk associated with
decreased and increased HRV in the elderly may
partly be explained by selective survival. Men with
heart disease die at a younger age than women, and
men who live to an older age may be healthier than
women of the same age. Moreover, the risks associ-
ated with decreased and increased HRV were more
pronounced in those aged <75 years, suggesting that
those who survive to older ages are less susceptible to
disturbances of HRV, possibly because of other
unknown characteristics. The risks of both decreased
HRV and increased HRV for cardiac mortality were
more clear in subjects with a history of myocardial
infarction. This suggests that ischemic heart disease is
involved in the mechanism controlling HRV.
However, HRV was also associated with cardiac death
in subjects without a history of myocardial infarction,
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TABLE 2. Age-adjusted hazard ratios for cardiac, noncardlac, and all-cause mortality, by quartlle of
heart rate variability (defined as SDNN*), relative to the third quartile:The Rotterdam Study, 1990-1996
Outcome Group
Cardiac mortality All subjects
Men
Women
No myocardial
infarction
Myocardial
infarction
Age £75 years
Age >75 years
Noncardiac mortality All subjects
Men
Women
All-cause mortality All subjects
Men
Women
1
HR*
1.8
1.3
2.5
1.6
2.4
2.0
1.6
1.3
1.1
1.5
1.4
1.1
1.7
1
95% Cl*
1.0, 3.2
0.6, 2.8
1.1,5.8
0.8, 3.0
0.8, 7.2
0.8, 5.4
0.8, 3.2
0.9,1.8
0.7, 1.7
0.9. 2.5
1.0,1.8
0.8, 1.7
1.1,2.6
Quartlle of SDNN
2
(9.6-<15.2)
HR
1.7
1.6
2.0
1.3
3.2
2.8
1.2
1.2
0.8
1.7
1.3
1.0
1.8
95% Cl
1.0, 3.1
0.7, 3.4
0.8, 4.8
0.6, 2.5
1.0,9.6
1.1,7.2
0.6, 2.5
0.9, 1.7
0.5,1.3
1.1,2.8
1.0, 1.8
0.7, 1.5
1.2,2.7
3t
(15.2-<25.9)
1
1
1
1
1
1
1
1
1
1
1
1
1
HR
2.3
2.0
2.7
2.0
3.2
3.8
1.6
1.1
0.9
1.6
1.4
1.1
1.9
4
(£25.9)
95% Cl
1.3,4.0
1.0,4.2
1.1, 6.4
1.0, 3.9
1.1,9.8
1.6,9.5
0.8, 3.2
0.8, 1.6
0.5, 1.4
1.0,2.7
1.0, 1.9
0.7, 1.6
1.2, 2.9
• SDNN, standard deviation of normal R-R intervals (In may, HR, hazard ratio; Cl, confidence interval.
t Reference category.
which may indicate that HRV is also a marker for sub-
clinical disease.
Prior studies assessing the risk for future morbidity
and mortality associated with HRV in the general pop-
ulation have consistently shown an association of
decreased HRV with cardiac and all-cause mortality in
middle-aged persons (17, 18-20). An association
between increased HRV and mortality has never been
reported for middle-aged subjects. In elderly popula-
tions, however, contradictory results have been
reported for the risks associated with both decreased
HRV and increased HRV. In the Framingham Heart
Study (16), a linear association between decreased
SDNN and all-cause mortality was present in men and
TABLE 3. Adjusted* hazard ratios for cardiac, noncardlac, and all-cause mortality, by quartlle of heart
rate variability (defined as SDNNt), relative to the third quartlle: The Rotterdam Study, 1990-1996
Quartne of SDNN
Outcome Group
HR* 95% Cl*
(9.6-^:15.2)
~HR 95% Cl
3*
(15.2-<25.9)
4
(£25.9)
HR 95% Cl
Cardiac mortality
Noncardiac mortality
All-cause mortality
All subjects
Men
Women
All subjects
Men
Women
All subjects
Men
Women
1.8
1.4
2.4
1.2
0.8
1.4
1.3
1.1
1.6
1.0,3.3
0.6, 3.0
1.0,5.6
0.9, 1.7
0.5, 1.3
0.9, 2.4
1.0, 1.8
0.7. 1.6
1.1.2.5
1.7 1.0,3.1
1.6 0.7, 3.5
2.0 0.8,5.0
1.2
0.8
1.7
1.3
1.0
1.8
0.9, 1.7
0.5,1.3
1.1,2.8
1.0, 1.8
0.7, 1.5
1.2,2.8
2.3 1.3,3.9
2.0 1.0,4.2
2.4 1.0,5.8
1.1
.0
.4
.4
.1
.7
0.8, 1.6
0.6, 1.6
0.9, 2.4
1.0, 1.8
0.7, 1.6
1.1,2.6
* Adjusted for age, sex (if applicable), diastolic blood pressure, body mass index, diabetes meiiitus, negative T
waves, mean R-R interval, and overall Q-Tc interval.
t SDNN, standard deviation of normal R-R intervals (in ms); HR, hazard ratio; Cl, confidence interval.
| Reference category.
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women aged >63 years, suggesting the absence of an
association of increased HRV with mortality. In the
Zutphen Study (17), the risk associated with reduced
HRV was less pronounced in men aged >65 years than
in middle-aged men, and an association of increased
HRV with all-cause mortality was present only in
elderly men. Finally, in the Bronx Aging Study (21),
among men and women aged 75-85 years, no associa-
tion was present between decreased HRV and cardiac
or all-cause mortality, but an association of increased
HRV with cardiac events was present in women.
The absence of an association of increased HRV
with mortality in some of these studies may partly be
explained by exclusion criteria and procedures used to
measure HRV. Upon visual inspection, one can clearly
see that increased HRV is accompanied by irregular
sinus arrhythmia. However, using the conventional
editing rules and measures for HRV, this irregular
HRV cannot be distinguished from normal sinus
arrhythmia. When these irregular sinus beats are con-
sidered abnormal, the risk associated with increased
HRV might be reduced, but proper definitions for
abnormal sinus beats are lacking. In addition, age dif-
ferences between study populations are likely to
account for part of the discrepancies.
In the present study, we analyzed HRV in quartiles of
SDNN. The fact that the third quartile was associated
with the lowest mortality may only be an approximate
indication of the true underlying relation. The nonlinear
association between HRV and cardiac outcome could
be studied in more detail by using finer categories of
SDNN. In this study, however, the numbers were too
small to allow for a sophisticated analysis.
Presumably, increased HRV, unlike decreased HRV,
is hardly influenced by the autonomic nervous system
but rather may be due to sinus node dysfunction (33,
34). With increasing age, pathologic changes occur in
the sinoatrial node, including an increase in collagen
and elastic fibers (35). Pathologic studies performed in
patients with sick sinus syndrome showed that an
increased amount of fibrous tissue was present in the
sinus node, apart from defects due to coronary arte-
riosclerosis (36). It has been shown that intrinsic sinus
node function, which is measured after autonomic
blockade, deteriorates with age, resulting in prolonged
R-R intervals and increased, irregular HRV (37, 38). In
the present study, persons with increased HRV had
longer R-R intervals, on average. The finding that the
risk associated with increased HRV was more pro-
nounced for cardiac mortality than for noncardiac and
all-cause mortality indicates that increased HRV is
influenced by ischemic heart disease.
Standard measures of decreased HRV mainly reflect
changes in autonomic balance (39, 40). Autonomic
dysfunction, i.e., sympathetic overactivity and a
decrease in vagal activity, results in increased heart
rate and, consequently, decreased HRV. Changes in
autonomic balance result from coronary heart disease,
but they can also be due to other disease processes (2,
3, 31-43), as is suggested by the increased risk of non-
cardiac mortality with decreased HRV observed in our
study. The biologic meaning of SDNN measured in
electrocardiographic recordings of 10 seconds will
only partly match that of SDNN derived from longer
periods, since some physiologic determinants simply
cannot be measured within 10 seconds. Further studies
are needed to clarify what these short term measures
reflect physiologically.
In conclusion, HRV measured on the standard 10-
second electrocardiogram can be used to identify older
men and women with increased risk for cardiac mor-
tality. In the elderly, increased HRV is an even stronger
indicator of cardiac mortality than decreased HRV.
Further studies are needed to confirm these findings
and to elucidate their biologic meaning.
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